Patent · US Active

Heteroaryl butanoic acid derivatives

US11453651B2 · kind B2 · utility

0Cited by

5References

31Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Birgit Bollbuck · Munich, DE
Christian Markert · Herbrechtingen, DE
Wolfgang Miltz · Basel, CH
Till Roehn · Zürich, CH

Key dates

Filing date	Feb 13, 2018
Grant date	Sep 27, 2022
Priority date	—
Expiry date	Apr 28, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention describes novel heteroaryl butanoic acid derivatives that are good drug candidates especially with regard to leukotriene A4 hydrolase (LTA4H). The present invention also relates to pharmaceutical compositions comprising said novel heteroaryl butanoic acid derivatives, methods of using said compounds in the treatment of various diseases and disorders, and processes for preparing the said novel compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.